Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)

NCT00431145 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Niacin
DRUG: Niacin+Statin

Sponsor

Ludwig-Maximilians - University of Munich